Results
74,063 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Vogelstein R JacobDirector |  IAMIambic Therapeutics, Inc.Derivative conversion | C | — 2.00M sh | Oct 19, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 2.00M sh | Oct 19, 2026 |
| 9 | Vogelstein R JacobDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 122.7K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Polovitz MarkTRUSTEE | NONESterling Real Estate Trust Grant or award | A | $923 38 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Carlsen ElyseCAO |  RSGREPUBLIC SERVICES, INC.Grant or award | A | $161 1 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Flower JohannaDirector |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $255K 1,129 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Flower JohannaDirector | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $338K 1,487 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 |  Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $824K 3,406 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Sarvikas JuhoDirector, Chief Executive Officer |  INSGINSEEGO CORP.Tax withholding | F | $15K 3,657 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Crowley Kyle BradfordDirector |  PUMPProPetro Holding Corp.Grant or award | A | — 11.8K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Baumgartner FlorianEVP and CEO, Vista |  CMPRCIMPRESS plcTax withholding | F | $36K 487 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $593K 2,439 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $332K 1,360 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Tolia Nirav NDirector, CEO and President, 10% Owner |  NXDRNextdoor Holdings, Inc.Option exercise | M | — 110.5K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Burnett VeraCFO and Treasurer |  EBFENNIS, INC.Option exercise | M | $35K 2,000 sh | Oct 19, 2026 traded Oct 19, 2026 |
| 9 | Carlson Michael PaulGENERAL COUNSEL & SECRETARY | NONESterling Real Estate Trust Grant or award | A | $172 7 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 122.7K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $305K 1,246 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Flower JohannaDirector | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $798K 3,520 sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Secora MichaelCFO & Chief Corp Dev Ofcr | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 61.3K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Cain James PDirector |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Grant or award | A | — 168 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Schreiner Megan E.PRESIDENT | NONESterling Real Estate Trust Grant or award | A | $60.4 2 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Lisowski CraigPresident of Products | NXDRNextdoor Holdings, Inc. Option exercise | M | — 178.6K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Dianaty AliEVP Ch. Prod. & Tech Officer |  MMEDMiniMed Group, Inc.Grant or award | A | — 11.1K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Rachlin Evan LockwoodDirector | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 57.8K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Hammes Gregory P.TRUSTEE | NONESterling Real Estate Trust Grant or award | A | $546 23 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Hammes Gregory P.TRUSTEE | NONESterling Real Estate Trust Grant or award | A | $192 8 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Siegrist Jonathan PhilipEVP of R&D & CTO |  QDELQuidelOrtho CorpOption exercise | M | — 18.7K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.14M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 1.46M sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Kiernan MichaelChief Revenue Officer | NXDRNextdoor Holdings, Inc. Option exercise | M | — 27.6K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 742.5K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $658K 47.6K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 731.2K sh | Oct 19, 2026 traded Oct 16, 2026 |
| 9 | Tolia Nirav NDirector, CEO and President, 10% Owner | NXDRNextdoor Holdings, Inc. Option exercise | M | — 45.1K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Scruggs Todd N.SVP, CFO |  HPHelmerich & Payne, Inc.Tax withholding | F | $18K 481 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Grayson Bruns HDirector |  RBBNRibbon Communications Inc.Grant or award | A | — 19.2K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Kiernan MichaelChief Revenue Officer | NXDRNextdoor Holdings, Inc. Option exercise | M | — 65.0K sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Thomsen Joel S.TRUSTEE | NONESterling Real Estate Trust Grant or award | A | $1,594 66 sh | Oct 19, 2026 traded Oct 15, 2026 |
| 9 | Catalio Capital Management, LP10% Owner | IAMIambic Therapeutics, Inc. Derivative conversion | C | — 2.00M sh | Oct 19, 2026 traded Oct 16, 2026 |